Doctors push new blood tests for colon cancer
Digest more
Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not ...
The Canadian Partnership Against Cancer, one of the funders of the research, said while Canada's overall average survival generally compares well, there was often more disparity a ...
A new study has found evidence linking the use of GLP-1 medications like Ozempic and Wegovy to lower death rates in colon cancer patients. The University of California, San Diego study examined ...
In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took ...
Hosted on MSN
Survival rates for cancer are the highest they’ve ever been — but these 3 will cause the most deaths in 2026
Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time ...
Colon cancer is now the leading cause of cancer death in people under the age of 50, according to the American Cancer Society, but what's behind the alarming surge and why are cases shifting?
Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading ...
Tribune Content Agency on MSN
Mayo Clinic Q&A: What do you know about colon cancer?
I received a notice from my health system that I’m due for a colorectal cancer screening. I’m 45. Do I really need to have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results